NCT06068738 - Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 14, 2023

Primary Completion Date

August 14, 2024

Study Completion Date

August 14, 2024

Conditions

Epithelial Ovarian Cancer

Interventions

OTHER

Biological sample collection

Collection of ascites, blood and fresh tumour tissues (if available)

Trial Locations (4)

Med. Universität Wien - Universitätsklinik für Frauenheilkunde, Vienna

Barmherzige Schwestern Linz, Abteilung Gynäkologie und Geburtshilfe, Linz

Evang. Kliniken Essen-Mitte gGmbH, Essen

Department für Frauengesundheit/Universitäts-Frauenklinik Tübingen, Tübingen